Rick Uhlmann, College of Business and Behavioral Science
March 22, 2016
Peter Huber, senior fellow at the Manhattan Institute for Policy Research and prominent Washington, D.C. attorney, spoke at Clemson University on April 12, 5-6:30 p.m., in 100 Hardin Hall as part of the Clemson Information Economy Project.
An author of several books, Huber spoke on his latest title, “The Cure in the Code: How 20th Century Law is Undermining 21st Century Medicine.” The discussion focused on Huber’s argument that obsolete policies and government regulation are impeding growth of DNA-focused medical treatments.
Huber cites molecular medicine advances that are producing “designer drugs,” which offer cures customized to each patient. Yet, such therapies are routinely blocked because of new-drug approval restrictions imposed by the Food and Drug Administration. Huber argues progress will be thwarted until new rules are crafted that will allow for scientific breakthroughs now possible.
Before joining the Manhattan Institute, where he writes on drug development, energy, technology, and the law, Huber was an associate professor at MIT. He clerked on the D.C. Circuit Court of Appeals for Ruth Bader Ginsburg and on the U.S. Supreme Court for Sandra Day O’Connor. Huber has a J.D. from Harvard University and a Ph.D. in mechanical engineering from MIT.
The Information Economy Project supports academic research, policy analysis, and popular commentary using economic theory and empirical methods to evaluate the challenges facing policy makers, judges and entrepreneurs.
For more information on the April 12 lecture, contact Kaitlin Matheson email@example.com.